MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS

被引：63
作者：
INABA, T
JURIMA, M
NAKANO, M
KALOW, W
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 05期
关键词：
D O I：
10.1038/clpt.1984.238
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：670 / 676
页数：7
相关论文
共 22 条
  • [1] ASLANIAN W, 1983, PHARMACOLOGIST, V25, P218
  • [2] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
  • [3] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
    EICHELBAUM, M
    BERTILSSON, L
    SAWE, J
    ZEKORN, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
  • [4] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
  • [5] THE GENETIC-CONTROL OF SPARTEINE AND DEBRISOQUINE METABOLISM IN MAN WITH NEW METHODS OF ANALYZING BIMODAL DISTRIBUTIONS
    EVANS, DAP
    HARMER, D
    DOWNHAM, DY
    WHIBLEY, EJ
    IDLE, JR
    RITCHIE, J
    SMITH, RL
    [J]. JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) : 321 - 329
  • [6] A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE
    INABA, T
    NAKANO, M
    OTTON, SV
    MAHON, WA
    KALOW, W
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) : 860 - 862
  • [7] COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE
    INABA, T
    VINKS, A
    OTTON, SV
    KALOW, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) : 394 - 399
  • [8] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE
    INABA, T
    OTTON, SV
    KALOW, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 547 - 549
  • [9] JURIMA M, UNPUB DRUG METAB DIS
  • [10] THE UPJOHN-AWARD-LECTURE 1981 - THE METABOLISM OF XENOBIOTICS IN DIFFERENT POPULATIONS
    KALOW, W
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (01) : 1 - 12
123